XENON PHARMACEUTICALS INC. Operating Leases, Future Minimum Payments, Due in Three Years
XENON PHARMACEUTICALS INC. (XENE) had Operating Leases, Future Minimum Payments, Due in Three Years of $1.07 million as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-03-06
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.07M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.23M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.15M.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.09M.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $1.07M 10-K · filed 2019-03-06 |
| 2017-12-31 | $1.23M 10-K · filed 2018-03-07 |
| 2016-12-31 | $1.15M 10-K · filed 2017-03-08 |
| 2015-12-31 | $1.09M 10-K · filed 2016-03-08 |
| 2014-12-31 | $1.06M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |